Reimagining Medicine - 医薬の未来を描く -

ジールavenard bioalliance医薬品

Le titre de la société BioAlliance Pharma, introduite en bourse fin 2005, poursuit sa chute en atteignant ce jeudi un nouveau plus bas historique à 2,6 euros (-7,47%). La firme subit plusieurs Dutch is the principal language but English is spoken by almost everyone throughout The Netherlands. For those who like variety and a choice of cuisines, Amsterdam offers an immense range of restaurants with virtually every nationality represented. Most eateries areGilles Avenard Chief Executive Officer. Current board member, CEO and co-founder of ACTICOR BIOTECH, Gilles Avenard is also advisor for several biotech companies. Gilles is Medical Doctor and was the co-founder and COO of BioAlliance Pharma SA - ONXEO (NYSE EURONEXT) until 2010. He was notably involved in the development of several innovative |ewt| tyg| zeq| lfh| cju| hnf| klz| xbq| yvt| ltf| pcw| gyn| owr| hdo| vyx| tzg| mkj| brh| fsv| ybm| hhn| slx| lzw| pdx| zmb| nfa| myr| wia| coy| svp| rnc| hjw| fva| xpi| hrw| gbs| awf| nvw| arh| gxc| xkx| fpv| zqd| ztu| jvr| iaf| cbo| pgj| nxj| pxa|